The Report

Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses

54 reports and counting

Updated daily with latest market intelligence

Ginkgo Bioworks transforms synthetic biology industry with $350M IPO at $15B valuation

Ginkgo Bioworks achieves $15B valuation through $350M IPO funding, establishing dominance in the synthetic biology market with innovative synthetic biology platform for organism design and manufacturing.

BioSynthetic Materials

BioSynthetic Materials Raises $720M Series D for Revolutionary Synthetic Biology Technology

BioSynthetic Materials secures $720M in Series D funding at $10.8B valuation to pioneer breakthrough synthetic biology technology.

Zymergen transforms synthetic biology industry with $300M Series C at $3.2B valuation

Zymergen achieves $3.2B valuation through $300M Series C funding, establishing dominance in the synthetic biology market with innovative biomanufacturing platform for materials and chemicals.

Twist Bioscience secures $120M Series D for biotech innovation

Twist Bioscience raises $120M in Series D funding to advance its synthetic biology company manufacturing dna sequences and accelerate market growth.

BioSynth Labs raises $380M Series B in September 2025 funding round

BioSynth Labs secures $380M in Series B funding in September 2025, reaching $3.2B valuation to advance its synthetic biology platform for sustainable chemical manufacturing.

CanSino Biologics Headquarters - Office Location & Address

Discover CanSino Biologics's headquarters at West Area of TEDA, Tianjin, 300457. Vaccine research and development. Learn about the office facilities and work environment.

China Biologic Products

China Biologic Products Headquarters - Office Location & Address

Discover China Biologic Products's headquarters at 17 Science Park Rd, Beijing, 100176. Plasma-based biopharmaceutical products. Learn about the office facilities and work environment.